-
Track & Monitor
![]()
Artificial intelligence in technology: Gen AI models
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the technology industry’s Gen AI models within Artificial intelligence innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Gallbladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Gallbladder Cancer Drug Details: GEN-001 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Gastric Cancer Drug Details: GEN-001 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Solid Tumor Drug Details: GEN-001 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: GEN-001 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Extrahepatic Bile Duct Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Extrahepatic Bile Duct Cancer Drug Details: GEN-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1056 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEN-1056 in Solid Tumor Drug Details: GEN-1056 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1047 in Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GEN-1047 in Breast CancerDrug Details:GEN-1047 is under development for the treatment of solid tumors including breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1047 in Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GEN-1047 in Ovarian CancerDrug Details:GEN-1047 is under development for the treatment of solid tumors including breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1047 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GEN-1047 in Solid TumorDrug Details:GEN-1047 is under development for the treatment of solid tumors including breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1047 in Endometrial Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GEN-1047 in Endometrial CancerDrug Details:GEN-1047 is under development for the treatment of solid tumors including breast...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1053 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEN-1053 in Solid Tumor Drug Details: GEN-1053 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IMNN-001 in Epithelial Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IMNN-001 in Epithelial Ovarian Cancer Drug Details: GEN-1 (EGEN-001) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-3014 in Refractory Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GEN-3014 in Refractory Acute Myeloid Leukemia Drug Details:GEN-3014 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-3014 in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GEN-3014 in Relapsed Acute Myeloid Leukemia Drug Details:GEN-3014 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-3014 in Diffuse Large B-Cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GEN-3014 in Diffuse Large B-Cell Lymphoma Drug Details:GEN-3014 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-1047 in Squamous Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GEN-1047 in Squamous Non-Small Cell Lung CancerDrug Details:GEN-1047 is under development for the treatment of solid...
-
Thematic Analysis
New![]()
Retail Banking Sector Scorecard – Thematic Intelligence
Retail Banking Sector Scorecard Thematic Intelligence Report Overview The retail banking sector scorecard includes a variety of traditional financial services providers, including global banks, national banks, regional banks, and building societies/mutuals. including global banks, national banks, regional banks, and building societies/mutuals.The retail banking sector scorecard thematic intelligence report identifies the 10 most disruptive themes that will drive market performance in the next 12 months. Generative AI (Gen AI) is a subset of AI that exploded into the mainstream following the...
-
Thematic Analysis
New![]()
Generation Z in Travel and Tourism – Thematic Intelligence
Gen Z in Travel and Tourism Thematic Report Overview In 2023, Generation Z accounts for people aged between 11 and 26. Asia has the largest Gen Z population at 1.2 billion, followed by the Middle East and Africa with 470 million. This generation uses social media before, during, and after a trip, making it a key component throughout the travel journey. It is increasingly important that destination marketing organizations (DMOs) and travel companies harness this tool as a result. ‘Instagrammable’...
-
Thematic Analysis
![]()
Generation Z in Tech, Media and Telecom – Thematic Intelligence
Explore trends and insights from the following data in our ‘Generation Z in TMT’ thematic report: The report looks at the impact of Generation Z on the Tech, Media, and Telecom (TMT) sectors. It includes a demographic briefing, which identifies the key characteristics of the different cohorts alive today and analyzes the influence of Gen Z in China, the US, and India. It identifies the key trends relating to Generation Z, including environmental, social, and governance (ESG) factors, social media...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.